Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The anatolian journal of family medicine (Online), 2024-04, Vol.7 (1), p.21
2024

Details

Autor(en) / Beteiligte
Titel
Depression, Anxiety, Sleep Quality, and Biological Rhythms between Patients with COVID-19
Ist Teil von
  • The anatolian journal of family medicine (Online), 2024-04, Vol.7 (1), p.21
Ort / Verlag
Istanbul: Kare Publishing
Erscheinungsjahr
2024
Link zum Volltext
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • [LANGUAGE= "English"] INTRODUCTION: This study aimed to explore depression, anxiety, sleep quality, biological rhythms, and risk factors related to taste and smell loss in COVID-19 patients.METHODS: This case-control study was conducted as a single-center study between January 1 and May 15, 2021. The study included COVID-19 patients and healthy adults as the control group. Depression Anxiety Stress Scale Short form (DASS-21), Biological Rhythms Assessment Interview in Neuropsychiatry, and Pittsburgh Sleep Quality Index (PSQI) were administered to the patients and control group.RESULTS: A total of 247 individuals (123 [49.7%] patients with COVID-19 and 124 [50.3%] control group) were included in the study. A total of patients with COVID-19 include 60 (48.7%) hospitalized-treated groups (HTG) and 63 (51.3%) home-treated groups (HOG). DASS-21 score, BRAIN score, and PSQI score in the patient group were higher than the control group (20.0±11.5 vs. 8.8±4.8, p<0.001 for DASS-21 score, 40.1±8.6 vs. 33.4±6.3, p<0.001 for BRAIN score, 5.2±3.0 vs. 2.9±1.5, p<0.001 for PSQI score). Anxiety score and PSQI score in the HTG were significantly higher than the HOG (7.4±3.7 vs. 5.1±4.2, p<0.001 for anxiety score, 5.8±2.9 vs. 4.6±3.0, p=0.013 for PSQI score). Age (Odds Radio [OR]=1.038, 95% confidence interval [CI]=1.010–10.67, p=0.007) and gender (OR=6.012, 95% CI=2.533–14.271, p<0.001) were determined as risk factors for developing taste/smell loss in COVID-19.DISCUSSION AND CONCLUSION: It can be stated that patients with COVID-19 have a higher risk of developing mood disorders, irregularity in biological rhythms, and sleep disorders compared to the control group. In addition, age and gender variables are directly related to taste and smell disorders in COVID-19.
Sprache
Englisch
Identifikatoren
ISSN: 2630-5593
eISSN: 2651-3455
DOI: 10.5505/anatoljfm.2024.42204
Titel-ID: cdi_proquest_journals_3049789887

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX